Literature DB >> 17008396

NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.

Jiping Zhang1, Mary Ann Warren, Suzanne F Shoemaker, Margot M Ip.   

Abstract

Nuclear factor kappaB (NFkappaB) plays an important role in mammary gland development and breast cancer. We previously demonstrated that TNF stimulates growth of mammary epithelial cells (MEC) in a physiologically relevant three-dimensional primary culture system, accompanied by enhanced DNA-binding of the NFkappaB p50 homodimer. To further understand the mechanism of TNF-stimulated growth of primary MEC, the requirement for NFkappaB1/p50, and the role of cyclin D1 in TNF-stimulated growth were examined. TNF induced the formation of DNA-binding complexes of p50 and p52 with their coactivator bcl3 in MEC nuclear extracts. Concomitantly, TNF increased the binding of NFkappaB proteins to the kappaB site on the cyclin D1 promoter, and increased expression of cyclin D1 mRNA and protein. Using MEC from p50 null mice, we found that p50 was not required for TNF-induced growth nor for up-regulation of cyclin D1. However, TNF induced a p52/RelB NFkappaB DNA-binding complex in p50 null MEC nuclear extracts. In addition, we found that in wild-type MEC, TNF stimulated the occupancy of p52 and RelB on the cyclin D1 promoter kappaB site, whereas p50 was present constitutively. These data suggest that in wild-type MEC, TNF stimulates the interaction of bcl3 with p50 and p52, and the binding of p52, as well as RelB, to cyclin D1 promoter kappaB sites, and as a consequence, stimulates the growth of MEC. In the absence of p50, p52 and RelB can compensate for p50 in TNF-stimulated growth and cyclin D1 induction in MEC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008396      PMCID: PMC1713261          DOI: 10.1210/en.2006-0500

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  55 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  The epidermal growth factor receptor is not required for tumor necrosis factor-alpha action in normal mammary epithelial cells.

Authors:  L M Varela; K M Darcy; M M Ip
Journal:  Endocrinology       Date:  1997-09       Impact factor: 4.736

Review 3.  The NFkappaB pathway and endocrine-resistant breast cancer.

Authors:  Y Zhou; S Eppenberger-Castori; U Eppenberger; C C Benz
Journal:  Endocr Relat Cancer       Date:  2005-07       Impact factor: 5.678

4.  Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA.

Authors:  D L Bundy; T W McKeithan
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

5.  Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.

Authors:  H Nakshatri; P Bhat-Nakshatri; D A Martin; R J Goulet; G W Sledge
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region.

Authors:  S Kitazawa; R Kitazawa; S Maeda
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

7.  NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition.

Authors:  M Hinz; D Krappmann; A Eichten; A Heder; C Scheidereit; M Strauss
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

8.  Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.

Authors:  D Joyce; B Bouzahzah; M Fu; C Albanese; M D'Amico; J Steer; J U Klein; R J Lee; J E Segall; J K Westwick; C J Der; R G Pestell
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

9.  Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.

Authors:  Yamei Zhou; Serenella Eppenberger-Castori; Corina Marx; Christina Yau; Gary K Scott; Urs Eppenberger; Christopher C Benz
Journal:  Int J Biochem Cell Biol       Date:  2005-05       Impact factor: 5.085

10.  Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture.

Authors:  G Franzoso; L Carlson; L Poljak; E W Shores; S Epstein; A Leonardi; A Grinberg; T Tran; T Scharton-Kersten; M Anver; P Love; K Brown; U Siebenlist
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

View more
  16 in total

1.  A Synthetic Loop Replacement Peptide That Blocks Canonical NF-κB Signaling.

Authors:  Paul A Bruno; Alex Morriss-Andrews; Andrew R Henderson; Charles L Brooks; Anna K Mapp
Journal:  Angew Chem Int Ed Engl       Date:  2016-10-28       Impact factor: 15.336

2.  Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κB.

Authors:  Michael J Flister; Lisa D Volk; Sophia Ran
Journal:  Microcirculation       Date:  2011-02       Impact factor: 2.628

3.  Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.

Authors:  Yu Tao; Zhanjie Liu; Yingyong Hou; Shouli Wang; Sanhong Liu; Yuhang Jiang; Dan Tan; Qiulin Ge; Cuifeng Li; Yiming Hu; Zhi Liu; Xi Chen; Qi Wang; Mingliang Wang; Xiaoren Zhang
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

4.  Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice.

Authors:  Anna Maria Malfitano; Silvio Sosa; Chiara Laezza; Marco De Bortoli; Aurelia Tubaro; Maurizio Bifulco
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

5.  t10,c12-CLA decreases adiposity in peripubertal mice without dose-related detrimental effects on mammary development, inflammation status, and metabolism.

Authors:  M R Foote; S L Giesy; G Bernal-Santos; D E Bauman; Y R Boisclair
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-15       Impact factor: 3.619

Review 6.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

7.  Increased H2O2 level in exhaled breath condensate in primary breast cancer patients.

Authors:  Robert A Stolarek; Elzbieta Potargowicz; Ewa Seklewska; Jarosław Jakubik; Marek Lewandowski; Arkadiusz Jeziorski; Dariusz Nowak
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-05       Impact factor: 4.553

8.  Identifying grade/stage-related active modules in human co-regulatory networks: a case study for breast cancer.

Authors:  Chenchen Feng; Lina Chen; Wan Li; Hong Wang; Liangcai Zhang; Xu Jia; Zhengqiang Miao; Xiaoli Qu; Weiguo Li; Weiming He
Journal:  OMICS       Date:  2012-12

9.  A cell cycle regulatory network controlling NF-kappaB subunit activity and function.

Authors:  Benjamin Barré; Neil D Perkins
Journal:  EMBO J       Date:  2007-10-25       Impact factor: 11.598

10.  Differential regulation of cyclin D1 expression by protein kinase C α and ϵ signaling in intestinal epithelial cells.

Authors:  Marybeth A Pysz; Fang Hao; A Asli Hizli; Michelle A Lum; Wendy M Swetzig; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2014-06-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.